Literature DB >> 23836830

Current evidence base for use of the implantable cardioverter-defibrillator.

Stefan H Hohnloser1, Carsten W Israel.   

Abstract

Keywords:  guideline; implanted cardioverter-defibrillators; risk

Mesh：

Year:  2013        PMID： 23836830     DOI： 10.1161/CIRCULATIONAHA.112.000547

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  11 in total

1.  Long-term use of the wearable cardioverter-defibrillator: prolonging life or prolonging indecision?

Authors:  Evan Adelstein
Journal:  J Interv Card Electrophysiol       Date:  2016-11-26       Impact factor: 1.900

2.  Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trial.

Authors:  José C Nicolau; Remo H M Furtado; Suzana A Silva; Carlos E Rochitte; Anis Rassi; João B M C Moraes; Edgard Quintella; Costantino R Costantini; Adrian P M Korman; Marco A Mattos; Hélio J Castello; Adriano Caixeta; Hans F R Dohmann; Antonio C C de Carvalho
Journal:  Clin Cardiol       Date:  2018-03-22       Impact factor: 2.882

3.  Long-Term Follow-Up of Catheter Ablation of Ventricular Arrhythmias: Experiences from a Tertiary Referral Center in Taiwan.

Authors:  Fa-Po Chung; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Yun-Yu Chen; Chuen-Wang Chiou; Shih-Ann Chen
Journal:  Acta Cardiol Sin       Date:  2015-01       Impact factor: 2.672

4.  Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: results from the NCDR.

Authors:  Daniel B Kramer; Kevin F Kennedy; John A Spertus; Sharon-Lise Normand; Peter A Noseworthy; Alfred E Buxton; Mark E Josephson; Peter J Zimetbaum; Susan L Mitchell; Matthew R Reynolds
Journal:  Heart Rhythm       Date:  2014-02       Impact factor: 6.343

5.  Impact of Cardiac Resynchronization Therapy on Left Ventricular Unloading in Patients with Implanted Left Ventricular Assist Devices.

Authors:  David M Tehrani; Sirtaz Adatya; Jonathan Grinstein; Daniel Rodgers; Nitasha Sarswat; Gene H Kim; Jayant Raikhelkar; Gabriel Sayer; Nir Uriel
Journal:  ASAIO J       Date:  2019-02       Impact factor: 2.872

6.  Stratifying patients at the risk of heart failure hospitalization using existing device diagnostic thresholds.

Authors:  Vinod Sharma; Lisa D Rathman; Roy S Small; David J Whellan; Jodi Koehler; Eduardo Warman; William T Abraham
Journal:  Heart Lung       Date:  2014-12-24       Impact factor: 2.210

Review 7.  The entirely subcutaneous defibrillator (s-icd): state of the art and selection of the ideal candidate.

Authors:  Elia De Maria; Alina Olaru; Stefano Cappelli
Journal:  Curr Cardiol Rev       Date:  2015

8.  Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.

Authors:  Fahad Almehmadi; Andreu Porta-Sánchez; Andrew C T Ha; Hadas D Fischer; Xuesong Wang; Peter C Austin; Douglas S Lee; Kumaraswamy Nanthakumar
Journal:  J Am Heart Assoc       Date:  2017-08-19       Impact factor: 5.501

Review 9.  Recent advances in the management of ventricular tachyarrhythmias.

Authors:  Syeda Atiqa Batul; Brian Olshansky; John D Fisher; Rakesh Gopinathannair
Journal:  F1000Res       Date:  2017-06-29

Review 10.  Novel approaches for the treatment of ventricular tachycardia.

Authors:  Michael Spartalis; Eleftherios Spartalis; Eleni Tzatzaki; Diamantis I Tsilimigras; Demetrios Moris; Christos Kontogiannis; Efthimios Livanis; Dimitrios C Iliopoulos; Vassilis Voudris; George N Theodorakis
Journal:  World J Cardiol       Date:  2018-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.